These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2149655

  • 1. Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
    Albus M, Maier W, Shera D, Bech P.
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):96-102. PubMed ID: 2149655
    [Abstract] [Full Text] [Related]

  • 2. Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
    Maier W, Albus M, Buller R, Nutzinger D, Shera D, Bech P.
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):103-8. PubMed ID: 2149648
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S.
    Acta Psychiatr Scand Suppl; 1991; 365():18-27. PubMed ID: 1862730
    [Abstract] [Full Text] [Related]

  • 4. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
    [Abstract] [Full Text] [Related]

  • 5. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [Abstract] [Full Text] [Related]

  • 6. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Mellergård M, Lorentzen K, Bech P, Ottosson JO, Rosenberg R.
    Acta Psychiatr Scand Suppl; 1991; 365():28-32. PubMed ID: 1862731
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of panic disorder patients responding to placebo.
    Rosenberg NK, Mellergård M, Rosenberg R, Beck P, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991; 365():33-8. PubMed ID: 1862732
    [Abstract] [Full Text] [Related]

  • 8. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 9. Patterns of response during placebo treatment of panic disorder.
    Mellergård M, Rosenberg NK.
    Acta Psychiatr Scand; 1990 Apr; 81(4):340-4. PubMed ID: 2188481
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 11. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Apr; 241(1):22-30. PubMed ID: 1832302
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R, McLeod DR, Zimmerli WD.
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [Abstract] [Full Text] [Related]

  • 13. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R, Maier W, Goldenberg IM, Lavori PW, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Aug; 240(3):163-8. PubMed ID: 1827602
    [Abstract] [Full Text] [Related]

  • 14. A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.
    Leon AC, Shear MK, Klerman GL, Portera L, Rosenbaum JF, Goldenberg I.
    J Clin Psychopharmacol; 1993 Oct; 13(5):327-31. PubMed ID: 8227491
    [Abstract] [Full Text] [Related]

  • 15. Validation criteria for panic disorder as a nosological entity.
    Rosenberg R, Ottosson JO, Bech P, Mellergård M, Rosenberg NK.
    Acta Psychiatr Scand Suppl; 1991 Oct; 365():7-17. PubMed ID: 1862735
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A.
    Acta Psiquiatr Psicol Am Lat; 1990 Oct; 36(1-2):59-72. PubMed ID: 2073024
    [Abstract] [Full Text] [Related]

  • 17. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 18. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K.
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [Abstract] [Full Text] [Related]

  • 19. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
    Sheikh JI, Swales PJ.
    Int J Psychiatry Med; 1999 May; 29(1):107-17. PubMed ID: 10376237
    [Abstract] [Full Text] [Related]

  • 20. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.